Table 3

The numbers and percentages of polymorphous low-grade adenocarcinomas in malignant minor salivary gland tumors by country as described in the studies included in this review
Country MMSGTs PLGA PLGA/MMSGTs
n % n % %
Australia 30 0.4 6 1.4 20.0
Austria 32 0.5 0 0.0 0.0
Brazil 356 5.2 20 4.6 5.6
China 2,683 38.9 83 19.3 3.1
Croatia 210 3.0 4 0.9 1.9
Denmark 266 3.9 66 15.3 24.8
Ecuador 14 0.2 0 0.0 0.0
England 384 5.6 33 7.7 8.6
Finland 118 1.7 19 4.4 16.1
German 226 3.3 29 6.7 12.8
India 197 2.9 18 4.2 9.1
Iran 16 0.2 0 0.0 0.0
Israel 104 1.5 11 2.6 10.6
Italy 50 0.7 1 0.2 2.0
Japan 98 1.4 0 0.0 0.0
Jordan 20 0.3 0 0.0 0.0
Kenya 58 0.8 0 0.0 0.0
Mexico 77 1.1 0 0.0 0.0
Niger 73 1.1 7 1.6 9.6
Paquistan 70 1.0 2 0.5 2.9
Sri Lanka 276 4.0 27 6.3 9.8
Switzerland 27 0.4 0 0.0 0.0
Tanzania 37 0.5 0 0.0 0.0
Thailand 201 2.9 3 0.7 1.5
Uganda 47 0.7 7 1.6 14.9
USA 1,193 17.3 95 22.0 8.0
Venezuela 28 0.4 0 0.0 0.0
Total 6,891 100.0 431 100.0 6.3

MMSGTs: malignant minor salivary gland tumors; PLGA: polymorphous low-grade adenocarcinoma.

de Araujo et al.

de Araujo et al. Diagnostic Pathology 2013 8:6   doi:10.1186/1746-1596-8-6

Open Data